Next Baby Powder Lawsuit Trial To Begin Next Week

The fourth talcum powder ovarian cancer lawsuit trial to take place before the City of St. Louis Circuit Court will begin on February 6.

Saturday, March 4, 2017 - The latest talcum powder ovarian cancer lawsuit trial to take place before the City of St. Louis Circuit Court started off in early February. It marked the beginning of the fourth talcum powder ovarian cancer trial before the court, which had previously heard three similar claims that all resulted in 10-figure damages being awarded to the plaintiff. The trial will be the latest attempt by Johnson & Johnson to receive a signature win against plaintiffs since the claims began to go to trial. Thus far there have been four losses in a row for Johnson & Johnson's, with the latest three al receiving large damage awards from the defendant.

The plaintiffs in the talcum powder ovarian cancer lawsuits claim that Johnson & Johnson intentionally refrained from warning consumers about the carcinogenic link between their talcum powder products and ovarian cancer, which had been published in medical journals more than 20 times. This evidence has bolstered the Johnson & Johnson's baby powder lawsuits that have been filed against the company, and the most recent trial that began in St. Louis will be another opportunity for that evidence to stand against the company's assertion that it has done nothing wrong.

THe three previous trials to take place before the City of St. Louis Circuit Court resulted in nearly $200 million in damages combined for three plaintiffs. The first plaintiff passed away shortly before her trial began and her estate was awarded $72 million dollars. The second two plaintiffs were still living and able to appear with their talcum powder attorneys in court. Those plaintiffs received $55 million and $70 million from the jury.

The momentum from those three talcum powder lawsuit trial results heads directly into the fourth case, with Johnson & Johnson desperately seeking a win in the course of litigation that has seen all the spoil go to the plaintiffs' side. The defendants even hired a new law firm to represent them in this case to try to improve the performance they had from previous trials. The allegations they face in the latest lawsuit remain similar to the one in the more than 2,000 Johnson & Johnson's baby powder lawsuits currently pending nationwide. Plaintiffs claim the company was aware of the carcinogenic data published about its talcum powder products and chose not to warn consumers to protect the marketability of the baby powder brand.

Thus far, there has been enough evidence for juries to side with the plaintiffs. There are more than 20 medical studies that have been published and presented as evidence during the trials, in addition to internal documents recovered by talcum powder lawyers representing the plaintiffs. These documents show that Johnson & Johnson had information regarding the studies conducted into the links between talcum powder and ovarian cancer as far back as 1995.

The beginning of the trial will come almost exactly a year after the first one began in 2016 in the City of St. Louis Circuit Court. Whether or not the plaintiff will win an award similar to the $72 million won a year ago will likely be determined within a month of the beginning of the trial.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.